161 related articles for article (PubMed ID: 31582836)
1. SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.
Smeester BA; Slipek NJ; Pomeroy EJ; Bomberger HE; Shamsan GA; Peterson JJ; Crosby MR; Draper GM; Becklin KL; Rahrmann EP; McCarthy JB; Odde DJ; Wood DK; Largaespada DA; Moriarity BS
Oncogene; 2020 Jan; 39(5):1049-1062. PubMed ID: 31582836
[TBL] [Abstract][Full Text] [Related]
2. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 4C Promotes Macrophage Recruitment and Angiogenesis in Breast Cancer.
Yang J; Zeng Z; Qiao L; Jiang X; Ma J; Wang J; Ye S; Ma Q; Wei J; Wu M; Huang X; Ma D; Gao Q
Mol Cancer Res; 2019 Oct; 17(10):2015-2028. PubMed ID: 31308149
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells.
Li X; Zhang C; Tian Y
J Mol Histol; 2021 Apr; 52(2):245-256. PubMed ID: 33394293
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development.
Maier V; Jolicoeur C; Rayburn H; Takegahara N; Kumanogoh A; Kikutani H; Tessier-Lavigne M; Wurst W; Friedel RH
Mol Cell Neurosci; 2011 Feb; 46(2):419-31. PubMed ID: 21122816
[TBL] [Abstract][Full Text] [Related]
6. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.
Hou Y; Wang W; Zeng Z; Gan W; Lv S; Li T; Yan Z; Zhang R; Yang M
Aging (Albany NY); 2020 Nov; 12(21):21992-22018. PubMed ID: 33177246
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 4C regulates ovarian steroidogenesis through RHOA/ROCK1-mediated actin cytoskeleton rearrangement.
Chen D; Wu C; Wei S; Guo Y; Wu M; Zhou S; Fu F; Tang W; Xue L; Zhang J; Li Y; Dai J; Li Y; Ye S; Wang S
Mol Hum Reprod; 2023 Apr; 29(5):. PubMed ID: 36892447
[TBL] [Abstract][Full Text] [Related]
8. Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.
Gurrapu S; Pupo E; Franzolin G; Lanzetti L; Tamagnone L
Cell Death Differ; 2018 Jul; 25(7):1259-1275. PubMed ID: 29555978
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated Lymphatic Endothelial Cells Promote Lymphatic Metastasis By Highly Expressing and Secreting SEMA4C.
Wei JC; Yang J; Liu D; Wu MF; Qiao L; Wang JN; Ma QF; Zeng Z; Ye SM; Guo ES; Jiang XF; You LY; Chen Y; Zhou L; Huang XY; Zhu T; Meng L; Zhou JF; Feng ZH; Ma D; Gao QL
Clin Cancer Res; 2017 Jan; 23(1):214-224. PubMed ID: 27401250
[TBL] [Abstract][Full Text] [Related]
11. The microRNA‑708‑5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma.
Feng T; Zhu Z; Jin Y; Wang H; Mao X; Liu D; Li Y; Lu L; Zuo G
Oncol Rep; 2020 Feb; 43(2):491-502. PubMed ID: 31894343
[TBL] [Abstract][Full Text] [Related]
12. Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells.
Gurrapu S; Franzolin G; Fard D; Accardo M; Medico E; Sarotto I; Sapino A; Isella C; Tamagnone L
Sci Signal; 2019 Aug; 12(595):. PubMed ID: 31431542
[TBL] [Abstract][Full Text] [Related]
13. Sema4C mediates EMT inducing chemotherapeutic resistance of miR-31-3p in cervical cancer cells.
Jing L; Bo W; Yourong F; Tian W; Shixuan W; Mingfu W
Sci Rep; 2019 Nov; 9(1):17727. PubMed ID: 31776419
[TBL] [Abstract][Full Text] [Related]
14. MAT1 facilitates the lung metastasis of osteosarcoma through upregulation of AKT1 expression.
Wang J; Ni J; Song D; Ding M; Huang J; Li W; He G
Life Sci; 2019 Oct; 234():116771. PubMed ID: 31421084
[TBL] [Abstract][Full Text] [Related]
15. Effect of microrna-138 on epithelial-Mesenchymal transition and invasion of breast cancer cells by targeting semaphorin 4C.
Liu H; Ye H; Li X
Bioengineered; 2021 Dec; 12(2):10117-10125. PubMed ID: 34747314
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
18. Silencing of CD44 gene expression in human 143-B osteosarcoma cells promotes metastasis of intratibial tumors in SCID mice.
Gvozdenovic A; Arlt MJ; Campanile C; Brennecke P; Husmann K; Born W; Muff R; Fuchs B
PLoS One; 2013; 8(4):e60329. PubMed ID: 23565227
[TBL] [Abstract][Full Text] [Related]
19. SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the PTEN Signaling Pathway.
Chen MW; Wu XJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818811143. PubMed ID: 30482097
[TBL] [Abstract][Full Text] [Related]
20. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
